Rafarma Pharmaceuticals, Inc. Named 1 Of 4 National Strategic Pharmaceutical Suppliers To The Russian Federation
January 31 2013 - 9:46AM
OTC Markets
Rafarma Pharmaceuticals, Inc. (the "Company") OTC symbol
"RAFA" announced that it has been named one of the four national
strategic Pharmaceutical Suppliers to the Russian Federation.
This important step for the company means it will receive
guaranteed government contracts helping load the manufacturing
facility to 100% capacity.
The Russian pharmaceutical industry supplies both the national
health care system and hospital sector with 70% of medicines in
physical volume. The Russian pharmaceutical market is considered to
be one of the most dynamic and growing in the world. It continues
to grow an average 10-12% per year since 2003 (Source: The Strategy
of Development of the Pharmaceutical Industry of the Russian
Federation,
http://www.osec.ch/de/filefield-private/files/25703/field_blog_public_files/5244).
CEO David Anderson stated, "This is a very exciting time for
the Company and we are extremely happy with the ability to be one
of the four national strategic Pharmaceutical Suppliers to the
Russian Federation."
As previously announced the Company will facilitate investor
awareness using social media. Follow Rafarma Pharmaceuticals
on Facebook at www.facebook.com/rafarmainfo or Twitter at
www.twitter.com/rafarmainfo. You can also text "RAFA" to 74499 to
receive updates via text message.
Safe Harbor Statement
Matters discussed in this press release contain
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. When used in this press
release, the words "anticipate," "believe," "estimate,"
"may," "intend," "expect" and similar expressions identify
such forward-looking statements. Actual results, performance or
achievements could differ materially from those contemplated,
expressed or implied by the forward-looking statements contained
herein. These forward-looking statements are based largely on the
expectations of the Company and are subject to a number of risks
and uncertainties. These include, but are not limited to: the
impact of economic, competitive and other factors affecting the
Company and its operations, markets, product, and distributor
performance.
SOURCE Rafarma Pharmaceuticals, Inc.
PR Newswire (http://s.tt/1zc1T)
Rafarma Pharmaceuticals (PK) (USOTC:RAFA)
Historical Stock Chart
From May 2024 to Jun 2024
Rafarma Pharmaceuticals (PK) (USOTC:RAFA)
Historical Stock Chart
From Jun 2023 to Jun 2024
Real-Time news about Rafarma Pharmaceuticals Inc (PK) (OTCMarkets): 0 recent articles
More Rafarma Pharmaceuticals, Inc. (WY) News Articles